Clinical Trial Update: Treatment of Severe Infection With Antihyperlipidemia Drug [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for an antihyperlipidemia drug being tested for severe infection in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• antihyperlipidemia drug (unspecified)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Sepsis, Septic Shock | Phase 2, Phase 3 | Status: UNKNOWN